Table 1.
Clinical characteristics of patients and tumors.
| Patient ID | Sex | Age at diagnosis | Clinical stage | Neoadjuvant treatment regimen | Surgical procedure | Pathology stage | Grade of response to treatment |
|---|---|---|---|---|---|---|---|
| NP01 | M | 54 | uT3N1 | Xeloda+50.4 Gy radiation | APR | ypT3N1b | 2 |
| NP04 | M | 61 | uT3N1 | Xeloda+50.4 Gy radiation | APR | ypT2N0 | 1 |
| NP10 | M | 60 | uT4N1 | Xeloda+50.4 Gy radiation | Exenteration | ypT3N1b | 2 |
| NP11 | F | 30 | uT4N2 | Xeloda+50.4 Gy radiation | LAR with Vaginectomy | ypT2N0 | 2 |
| NP12 | M | 54 | uT3N0 | Xeloda+50.4 Gy radiation | LAR | ypT2N0 | 2 |
| NP14 | M | 68 | mT2N1 | Xeloda+50.4 Gy radiation | APR | ypT3N0 | 1 |
| NP16 | F | 45 | mT4N1 | Xeloda+50.4 Gy radiation | APR | ypT4N1 | 1 |
| NP17 | F | 33 | uT3N1 | Xeloda+50.4 Gy radiation | LAR | ypT2N0 | 2 |
| NP18 | F | 53 | uT3N1 | Xeloda+50.4 Gy radiation | LAR | ypT2N0 | 2 |
| NP19 | F | 54 | mT4N0 | Xeloda+50.4 Gy radiation | LAR | ypT3N0 | 2 |
Clinical Stage is determined by endorectal ultrasound (u) or MRI (m) and is according to AJCC, 8th Edition; Gy = Gray; APR = Abdominoperineal resection of the rectum; LAR = Low anterior resection of the rectum; yp indicates pathology stage after neo-adjuvant treatment.